ADIPOQ and nasopharyngeal carcinoma: Owing to its well-established anti-inflammatory function, adiponectin can also prevent NPC development by suppressing proinflammatory cytokines such as IL6, tumor necrosis factor-α, and interferon γ [45], as well as inducing the expression of anti-inflammatory cytokines such as IL-10 and IL-1RA [46].